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 Increasing the efficiency of the methods used through the development and trial 
of novel pharmaceutical compounds is an important step to reduce the time required to 
develop new medical treatments. Before a drug can be used, multiple analyses are 
required to obtain their physical, chemical and biopharmaceutical properties. The aim of 
this thesis will be to show that SPME can be an advantageous technique in the field of 
pharmaceutical development due to its use both as a tool to determine the physical 
properties of drugs and to facilitate clinical development by easily and cheaply providing 
high-throughput analysis of compounds in biological fluids.  
It will be demonstrated that a novel coating of triacontyl is capable of rapid 
equilibrium while providing enhanced sensitivity towards benzodiazepines when 
compared to shorter chain alkyl extraction phases. The same extraction phase will 
prove capable of providing a rapid determination of the hydrophobicity of structurally 
diverse β-blocker drugs while maintaining the use of solvents and analyte to a minimum. 
We will then show the possibility to produce large quantities of fibers using a robotic 
apparatus for high-throughput handling of samples. The 96 fiber plate produced will 
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 Pharmaceutical innovation and development is directly linked to scientists’ ability 
to monitor drugs as they are developed, including monitoring the drugs in biological 
fluids. The fast and efficient monitoring of drugs into our bodies is both a fascinating and 
a daunting task. As rugged methods are developed with higher efficiencies, new 
medications can be investigated more efficiently and therefore, increase the chances of 
new treatments reaching consumers faster. While many analytical methods deal with 
the analysis of compounds in air or water, pharmaceutics are normally concerned with 
living organisms; either animal or human. This involves the analysis of complex 
matrices such as hair, saliva, urine, blood and tissue homogenates to name a few. 
These samples contain other components, such as proteins, lipids, cells, in much larger 
quantities than the analyte itself. The way to properly analyze these matrices often 
means increased sample preparation. These extra steps tend to increase the workload 
for the analyst, increase the time necessary to get meaningful results and increase the 
likeliness of instrument failures or contamination. A constant concern is also the risk of 
infection the analyst faces when exposed to biological material when a lot of 
manipulation is involved. In this regard, more efficient sample preparation benefits the 
patients, the industry and the analyst. 
Pharmaceutical compounds are administered in wide dosage concentrations and 
possess varied physical properties. Understanding their pharmacokinetic and physical 
properties is important to prevent unwanted side effects and toxicity. Development of 
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sample preparation methods that improve sample clean-up and preconcentration of 
analytes are therefore an important part of analytical research to help characterise 
these properties. The present work focuses on solid phase microextraction (SPME) as a 
means to efficiently quantify drugs due to the unique blend of qualities this method 
involves, as described later on. 
 
1.1 SPME Background 
 
Solid phase microextraction is a sorptive technique where selected coating 
chemistries are used to perform the extraction of analytes.1 Developed in the early 
1990’s by Pawliszyn et al., the technique presents many advantages to the analytical 
chemist including: 
-Ease of use 
-Rapidity of analysis 
-Preconcentration of analyte 
-Small and practical format 
-Amenable to automation 
-Minimal use of toxic solvents 
 The SPME technique initially developed into a powerful tool for the analysis of 
environmental pollutants and also provided an opportunity for better in situ analysis in 
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this domain. Since then, SPME has gained popularity in a wide range of fields where 
the advantages mentioned above were needed such as food analysis, forensics and 
industrial applications to name a few. The physical design of the fiber itself is quite 
simple, generally consisting of a rod-like support usually made of fused silica or metal, 
and a stationary phase of controlled length and thickness. In order to understand how 
SPME is designed and how it is used, we must describe some of the underlying 
mechanisms of the technique. In the present thesis, only the theory pertaining to direct 
immersion of the stationary phase into the sample is relevant. The method of 
headspace extraction, although attractive in some applications because of minimal 
matrix effects, is not advantageous in our case due to the non-volatile nature of 
pharmaceutical compounds. 
 
1.1.1 Thermodynamic Theory 
 
The great qualities of SPME stem from the fact that the stationary phase can be 
chosen to match the type of analyte of interest. A proper choice of stationary phase can 
greatly help quantitate compounds, mainly by using a stationary phase with greater 
affinity to the analyte of interest, therefore increasing the sensitivity of the method. 
Analytes of low polarity will have greater affinity to a hydrophobic stationary phase 
whereas the opposite is true for highly polar compounds.  As the analyte is partitioning 
into the stationary phase, an equilibrium is reached in time where the extracted amount 
becomes constant. The equilibrium conditions are defined as:   
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                                               𝑛 =
𝐾𝑓𝑠𝑉𝑓𝑉𝑠𝐶𝑜
𝐾𝑓𝑠𝑉𝑓+𝑉𝑠
                                                  [1] 
Where n is the amount extracted by the fiber, Kfs is the distribution constant between the 
coating and the sample, Vf is the fiber coating volume, Vs is the sample volume and Co 
is the initial concentration of the analyte in the sample.2 By allowing the microextraction 
to reach equilibrium, we are able to obtain reproducible results at the expense of some 
exposure time. It is clear from this equation that the amount of analyte extracted by the 
fibre is directly proportional to the initial concentration of our sample. In cases where the 
sample volume is negligible compared to the product of the distribution constant and the 
volume of the fiber, the equation takes the following simplified form: 
                                                  𝑛 = 𝑉𝑠𝐶𝑜                                     [2] 
If the sample volume is much larger than the product of the distribution constant and 
fiber volume, the equation takes the following form: 
     𝑛 = 𝐾𝑓𝑠𝑉𝑓𝐶𝑜                   [3] 
Generally, once a target analyte in a given sample is proposed, and a suitable 
stationary phase is found, we must look at kinetic parameters to improve the 




1.1.2 Kinetic Theory 
 
The kinetic model proposed is a useful tool for the SPME user to increase 
productivity without sacrifices. Since SPME probes tend to be small compared to the 
bulk size of the sample, designing an SPME method also means agitating the sample in 
a way that will bring analytes efficiently to the surface of the stationary phase.  The 
equation describing the time where equilibrium is reached is as follows: 
 𝑡𝑒 = 𝑡95% = 3
𝛿𝐾𝑓𝑠𝑏
𝐷𝑠
                        [4] 
Where b is the fibre coating thickness, Ds is the diffusion coefficient of the analyte of 
interest in the given sample and δ is the boundary layer thickness (See Figure 1).  
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Figure 1 Graphical representation of the boundary layer. 
 
 The boundary layer is a static layer at the surface of the coating where no 
agitation occurs, acting like a stagnant liquid, which hinders the flow of analyte to the 
fibre considerably. In order to reduce the thickness of this boundary layer, increased 
agitation of the bulk sample must be performed and can be accompanied with an 





1.2 SPME Coating Technologies 
 
At the basis, the qualities of SPME as a uniquely attractive extraction method can 
be attributed in large parts to the capacity of the fibres to have desired properties such 
as good analyte affinity, good capacity and even a desired selectivity (i.e. antibody 
coatings). It is by properly selecting or designing a fibre coating that the maximum 
potential of SPME can be achieved. In order to obtain a general idea of how SPME 
fibers are designed, it is necessary to discuss some background on the types of 
coatings involved in SPME. We will then discuss the technologies involved in applying 
these coatings successfully. 
 
1.2.1 Coating  Extraction Mechanisms 
 
A multitude of high pressure liquid chromatography (HPLC) and gas 
chromatography (GC) columns are available on the market simply because there is no 
perfect column which can separate any compounds in any conditions. For the same 
reason, SPME technology relies heavily on the quality and choices of its coatings to be 
able to target as many analytes in as many conditions as possible. Although there is no 
perfect SPME fiber, some have the ability to extract a large library of compounds, such 
as polydimethylsiloxane (PDMS) based fibers. Others are intrinsically efficient at being 
very selective towards only a few select compounds, such as molecularly imprinted 
polymers (MIP)3, 4 and antibodies5.  
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There are 2 types of coatings available commercially: liquid coatings and solid 
coatings.6 Liquid coatings, such as PDMS and poly(acrylate) (PA), extract the analyte 
through an absorption mechanism whereas the solid coatings, such as Carbowax (CW) 
based fibers, extract by adsorption (Figure 2).6  
 
Figure 2 Schematic representation of the extraction process of liquid and porous solid 
materials. 
Jiang et al. have classified coatings available as organic coatings and inorganic 
coatings.7 Organic coatings are popular because they are usually easier to apply on the 
fiber and they can be more easily modified to have different functional groups. Coatings 
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of this class are PDMS and chemically modified PDMS. These coatings tend to be very 
versatile and are not affected by competition for adsorption sites on the fibers. The 
fibers discussed throughout this thesis will be organic coatings where absorption will be 
the main mechanism of extraction. 
 
1.2.2 Coating Methodology 
 
1.2.2.1 Polymeric Materials 
 
By far, the most common SPME fibres consist of polymer based extraction 
phases. Amongst those, PDMS is most common, but other polymeric stationary phases 
are available, such as carbowax and divinylbenzene (DVB) based fibers.  The coatings 
are assembled simply by depositing the coating to the surface of a fused silica fiber. 
Generally the coating is applied by running the fused silica rods through the solution 
followed by heat or ultraviolet (UV) curing, or they are simply applied by hand, followed 
by attachment to the fiber assembly. Further explanation on the process can be found 
elsewhere.8 In 1997, polymer based adhesives were used to bind porous HPLC 
stationary phases on the surface of SPME fibers using Epotek epoxy adhesive.9  This 
approach was impressive due to an 8 fold increase in extraction using a 30 µm thick C8 
phase compared to a 100 µm thick PDMS phase. It was found that the fibers were 
rugged enough for GC injection, and they initiated interest due to their common 
extraction phase. This method of preparing the fibres would become popular for 
assembly of high capacity, HPLC compatible, fibers. Generally, these fibres are easy to 
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A popular approach to the development of a new fiber coating is the use of the 
sol-gel method. The sol-gel method generally involves the in situ generation of silica by 
base- or acid-catalyzed hydrolysis of tetramethoxy- or tetraethoxysilane in an alcohol-
water mixture.10 The sol-gel mixture consists of a “sol”, which is the solvent in a liquid 
form, and the “gel”, which is the non-soluble portion. Upon drying or catalysis, the 
product hardens and becomes glass-like. By exposing the resulting product to high 
temperatures, the polymerization of the silica is completed and residual solvents are 
removed.10 In 1997, Chong et al.11 were the first to propose the use of sol-gel 
technology to help improve SPME coating strategies. 
 Although SPME possesses many attractive advantages, some problems remain 
to be addressed regarding the coatings themselves. Most commercially available 
coatings have important drawbacks such as: (i) a relatively low recommended operating 
temperature (240-280 oC), (ii) instability and swelling in organic solvents (one of the 
biggest drawbacks to HPLC use), (iii) breakage of the fiber, (iv) stripping of the coating 
and (v) high cost.12 The lack of proper chemical bonding between the stationary phase 
and the fiber surface, and the relatively high thickness of traditional SPME fibers seems 
responsible for some of the drawbacks, namely, the low operating temperature, the 
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solvent instability and the stripping of coatings.12 The sol-gel coating technology has 
shown to be able to overcome these problems and create unbreakable fibers.12, 13 The 
sol-gel possesses many qualities that make it interesting for SPME coating purposes. It 
is a relatively mild reaction and it is also controllable in order to obtain different physical 
properties, such as increased porosity, as well as the possibility to covalently 
incorporate desired chemical moieties into the coating while maintaining a rugged 
coating.  
Although fiber coatings prepared using the sol-gel process have many 
advantages and improvements over traditional dip coatings, there remain some issues 
with the technique. The fabrication of a new coating using sol-gel necessitates a lot of 
optimization and the proper choices of precursor and catalyst. Much investigation is 
needed to determine the proper conditions such as temperature, concentration of 
reagents and proper curing. All the parameters can potentially have dramatic effects on 
the final product such as strength, uniformity and porosity of the coating.  In order to 
simplify the procedure, we have made use of silicate chemistry to create a primary 
coating which would serve as a solid primer where various organosilane attachments 
could be performed. We use a mixture of pre-synthesized solid porous silica and liquid 
potassium silicate in order to achieve a rugged coating. The porous silica particles are 
synthesized primarily for use in HPLC columns due to their ruggedness, high porosity 
(about 200 m2/g) and possibility to derivatize many stationary phases at their surface. 
They have been used extensively as a solid-phase extraction (SPE) cartridge material 
for similar reasons. The surface of these particles is made of reactive silanol groups 
(about 8 μmol/m2), which can be used to functionalize the particles with a stationary 
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phase.14 Silica is common in nature but is synthesized de novo in order to yield a pure 
particle (see Figure 3). The manufacturing of such particles is usually proprietary to 
companies producing these particles and a wide range of silica particles with many 
different physical properties are available.  
 
Figure 3 Formation of porous silica particles. 
 
An important characteristic, as discussed before, is the porosity of the silica 
particles which, depending on the curing conditions determined by the manufacturer, 
can result in different pore volumes, different surface areas and different densities of the 
particles. In order to be able to provide a good bond between the silica backbone and 
the hydroxyl surface of stainless steel, we used potassium silicate in aqueous solution, 
which once cured, creates a tough and highly adhesive film with the proper surface. 
Upon curing, strong chains of inorganic molecules are formed (see Figure 4). Besides 
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being a strong adhesive towards metals and glasses/ceramics, potassium silicate is 
non-toxic, cheap, resistant to water and extremely resistant to heat (i.e. up to 1600oC). 
 
 
Figure 4 SiO2 sol formed from silicic acid salt condensation.
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 Potassium silicate is used in a wide array of applications. It is used as an 
adhesive for corrugated boards, foil-to-paper lamination, masonry coating, briquetting, 
pelletizing, agglomerating, binding ceramics or powdered metals for high temperature 
coating applications, welding rod coatings, paint, protecting stainless steel from 
abrasion, corrosion and cleaning agents, coating of bulk rail car interiors to prevent 
corrosion and water pipes treatment.16  This rugged and versatile material is easy to 
work with and, coupled with the porous silica particles described previously, gave high 








1.3 Current Methods for Drug Analysis 
 
1.3.1 Classical  Approaches 
 
Nowadays, methods for drug analysis make use of breakthrough technologies 
developed with bioanalysis in mind (i.e. new HPLC columns or new instrument designs). 
Analysts are trying to look past the classical methods in order to avoid some of the 
problems associated with them, such as long analysis times. From an environmentally 
friendly point of view, liquid-liquid extraction (LLE) is an unfavourable method due to the 
use of toxic solvents in large quantities. LLE involves choosing a solvent in which the 
analyte of interest will partition, and mixing a considerable amount of the solvent with 
the sample. Since most drugs are non-polar, this often involves the use of ethers which 
are a health hazard both due to toxicity as well as extreme flammability. SPE, which 
uses a small cartridge to extract the analyte, can also necessitate a lot of solvent on the 
desorption step. The sample is usually fed through the cartridge by either pumps or 
vacuum. Once the analyte is retained on the cartridge, a large volume of desorption 
solvent, where the analyte prefers to partition, is run through the cartridge. This method 
is also a large consumer of toxic solvents. Furthermore, the cartridge is likely to get 
plugged since it is packed in a cartridge format. Hence, researchers are turning their 
attention towards more promising technologies, or trying to make older technologies 
more efficient (i.e. using automation). 
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1.3.2 Automation Oriented Approaches 
 
1.3.2.1 Solid Phase Extraction 
 
An example of an older technology made more efficient by automation is SPE. 
Normally carried out using a bulky vacuum apparatus and necessitating large volumes 
of solvent, SPE has been improved into an on-line method by incorporating it to HPLC. 
Unlike LLE, SPE is easier to bring to automation. This method usually consists of using 
2 pumps, one with a loading solvent (pump1) which allows the sample to be run through 
the SPE cartridge and promote analyte partitioning to the SPE cartridge (represented as 
RAM – for Restricted Access Material – in Figure 5). RAM is a particular material used 
as SPE sorbent, but with desirable qualities for direct biological sample clean-up 
(described further). Once the analyte is extracted to the cartridge, the second pump 
backflushes the analyte using a desorption solvent where the analyte will partition. The 
backflush acts as an injection in itself and a clean-up of the cartridge is performed 
simultaneously. Everything eluted from the SPE cartridge then follows the path to the 
traditional chromatographic column for separation, and finally to the detector for 
quantitation. This automation procedure is an interesting approach, especially with 
novel SPE cartridges which allow direct biosample clean-up. Some drawbacks are 
obvious, the large cost of obtaining a second high-pressure pump for the apparatus and 




Figure 5 Online sample clean-up using SPE column coupled to a traditional HPLC 
setup. 
  
1.3.2.2 In-tube Solid Phase Microextraction 
 
Recent technologies which are gaining popularity in the field of bioanalysis is in-
tube solid phase microextraction (in-tube SPME), which uses an open tubular capillary 
containing the desired extraction phase inside the tube. In-tube SPME has been used 
successfully in a variety of analyses such as the analysis of β-blockers in urine and 
serum samples17, as well as amphetamines in urine18, both with an omegawax 
stationary phase. Benzodiazepines were also analyzed successfully using a porous 
divinylbenzene stationary phase.19 Immunoaffinity in-tube SPME, a method where 
receptors with very specific affinity are affixed to the surface of the tube, was also 
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applied to analysis of 7-aminoflunitrazepam in urine 20 and to the analysis of fluoxetine 
in serum.21 In-tube SPME has the advantage of being easily automated, by inserting 
directly into the separation system, between the separation column and the injector 
(See Figure 6). This makes the method easy to optimize since autosampler 
programming allows us to determine optimal draw speed, draw cycles necessary and 
the volume of sample necessary, all this with minimal manual labour. This is ideal for 
quick method development while providing less chances of sample contamination or 
analyst contact with hazardous samples.  Although chances of plugging the capillary 
itself are low, one must still be careful to prevent plugging of the injector system; 
therefore care should be taken to have a homogeneous sample. 
 
Figure 6 In-tube SPME apparatus coupled to LC-MSD (A: extraction position, B: 
injection position).22 
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1.3.2.3 Solid Phase Microextraction 
 
Traditional SPME fibres have a design that is particularly attractive for bioanalysis 
because of the open-bed nature of the stationary phase, allowing easy access to the 
sample, with no risk of plugging the device. The potential for SPME as a technique 
which is ideally suited for automation was described in the early stages of the 
technique.23 Automation of SPME is now well established and usually implemented by 
the use of a robotic arm such as the CombiPAL and its direct coupling to a 
chromatographic system. This system assures minimal direct human contact with the 
various processes of SPME such as extraction, agitation and desorption procedures. 
This in turn minimizes risks of contamination, accidents and reduces the analysis time. 
Nowadays, efforts are being focused on parallel analysis due to the development of 96 
well plates, and more recently 384 and 1536 well plates. Since the extraction and 
desorption steps of the SPME process are the bottleneck of the technique, parallel 
sample preparation is therefore a very valuable high-throughput approach. Using this 
format, it is possible to considerably reduce extraction and desorption time and directly 
divide the time of the procedure by the number of samples run simultaneously. 
Automated SPME-LC is therefore a very valuable tool, especially since biological and 
environmental applications tend to generate numerous samples, in which case linear 
analysis may be impractical.24 Multi-well plates coupled to various formats of multi-fiber 
holders have been investigated previously and demonstrate the benefits of such 
methods for automation.25 The design has been since used for drug analysis and 
protein binding studies.26 Further developments in the automation apparatus such as 
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the robotic arm and the fiber assembly will make this technique increasingly popular and 
easy to use while saving the analyst precious time. 
 
1.3.3 Biocompatible Approaches 
 
The more recent developments in stationary phases for added ruggedness in 
biological sample applications are worth mentioning. Porous silica particles are 
advantageous due to their high surface area and physical stability; however common 
stationary phases covalently bonded to their surface have limited use in dirty samples. 
The macromolecules and coagulation factors present in biological samples can 
irreversibly alter the surface of the stationary phase and hinder normal mass transfer. 
Materials capable of withstanding the fouling created by multiple immersions in 
biological samples are often referred to as biocompatible. Silica particles used for 
analyte extraction which have been designed for this purpose are referred to as 
Restricted Access Materials (RAM) due to their capacity at “restricting access” of the 
fouling agents to the extraction surface. Some description of special surfaces that have 
been developed and successfully applied to biological sample clean-up and can 
therefore be reused are described here. 
The first RAM that was used for the clean-up of biological samples was named the 
Internal Surface Reversed Phase (ISRP) particles, which were introduced in 1985 by 
Hagestam and Pinkerton.27 The particles worked by physically blocking access of the 
plasma proteins to the reversed phase embedded within the pores of silica 
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chromatography particles. These particles consisted of a tripeptide stationary phase 
made of Glycine-L-Phenylalanine-L-Phenylalanine (GPP). They initially derivatized their 
particles with a glycerylpropyl bonded phase (using silanization with γ-
glycidoxypropyltrimethoxysilane) and subsequently covalently bound the GPP tripeptide 
with a carbonyldiimidazole (CDI) derivatization.28 The hydrophobic amino acids are then 
cleaved from the outside of the particles with the help of the enzyme Carboxypeptidase 
A. This enzyme cleaves the phenylalanine moiety, while leaving the remaining glycine-
diol on the surface to protect against protein adsorption and precipitation. It is important 
to note that since the size of the enzyme cleaving the outside stationary phase is 
smaller than most plasma proteins, it will have access more easily to the larger pores of 
the silica particle and therefore will prevent adsorption and precipitation of the protein by 
cleaving hydrophobic moieties of the large, potentially problematic pores. These 
researchers also demonstrated that smaller pore size diameter particles were resistant 
to a greater number of sample injections (240 injections for 80 +/- 30 Å) than their larger 
pore counterpart (about 50 injections for 123 +/- 30 Å). 
A more recent material is Alkyl Diol Silica (ADS), developed in 1995 by Boos et 
al.29 This material appeals particularly to analysts due to the common n-butyl (C4), n-
octyl (C8) and n-octadecyl (C18) stationary phases used and can therefore have a 
predictable affinity towards the desired analyte. It is also possible to have ion-exchange 
properties inside the pores of these ADS particles, in which case they are referred to as 
exchange diol silica (XDS). The particles are first reacted with 3-
glycidoxypropylmethyldimethoxysilane to obtain the glycerylpropyl coverage followed by 
butyroyl, capryloyl or stearoyl chloride to obtain the desired stationary phase. A 
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cleavage by lipases then effectively removes the hydrophobic surface reached by 
macromolecules and replaces them with a hydrophilic biocompatible surface where 
protein denaturation is prevented (see Figure 7). 
 
Figure 7 Surface derivatization followed by enzymatic cleavage of a pore at the surface 
of the RAM silica particles. 
 
The biocompatible approaches described above have been used throughout the 
field of bioanalysis and serve as a good example of the fabrication approaches which 
can be used for bioanalysis using custom SPME fibers. Although these technologies are 
currently mainly used in SPE sample preparation, new SPME coatings have also been 
built using these materials.30 These techniques and their applications show the 
importance of recent research to improve bioanalytical methods. It will be part of this 
thesis to demonstrate the capability of SPME as a bioanalysis tool to target 
pharmaceutical compounds in complex samples. We will achieve this using pre-
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derivatized particles and adhesive to assemble a large number of probes, without 
emphasis on reusability. 
 
1.4 Octanol-Water Partition Coefficient 
 
Another important analysis during the development of potential pharmaceutical 
compounds is the logarithm of the octanol-water partition coefficient (LogP). The LogP 
is defined as: 
𝐿𝑜𝑔𝑃 = 𝐿𝑜𝑔
 𝐴𝑛𝑎𝑙𝑦𝑡𝑒  𝑜𝑐𝑡𝑎𝑛𝑜𝑙
 𝐴𝑛𝑎𝑙𝑦𝑡𝑒  𝑤𝑎𝑡𝑒𝑟
    [5] 
It is important to understand that it is the logarithm of the unionized analyte. If the 
compound is ionized during the measurement a different equation applies and we would 
use LogD instead of LogP. 
 The LogP parameter is an important part of the pharmaceutical development 
process. It is used to screen compounds in the early stages of development and 
indicates the likelihood that the compound could progress and eventually be successful 
as a drug. Pharmaceutical compounds must possess the right set of physical properties 
to have proper ADME (Absorption, Distribution, Metabolism, Excretion) characteristics.31 
In order to know if a novel compound meets these characteristics, multiple tests are 
carried out in order to help predict the potential of the compound in vivo. LogP is 
generally one of the first parameters studied because if the values are outside 
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specifications, the compound is either too hydrophilic or too hydrophobic to have ideal 
ADME in the body, although some exceptions occur. A compound which is too 
hydrophilic might get excreted too fast to even have time to create a desired effect, 
whereas a compound with a high hydrophobicity might not make it into the body at all 
due to poor intestinal membrane absorption. Traditionally, LogP is obtained using the 
shake flask method, which consists of mixing a large amount of octanol and water into a 
flask and a considerable amount of drug into the mixture followed by shaking of the 
flask. The method would clearly benefit from reducing the amount of compound as well 
as solvents used, which is the reason we have used SPME to investigate an alternative 
















1.5 Thesis Objectives 
 
The objective of this work will be to show the capabilities of SPME as a tool for 
high-throughput analysis of pharmaceutical compounds. A rapid and simple way to help 
determine the hydrophobicity of compounds using SPME will be described as well as a 
high-throughput multi-fiber method for the determination of a target compound in a 
complex matrix. 
The first objective will demonstrate a new technique to assemble a porous silica 
coating which can be derivatized using organosilane chemistry, commonly used for 
HPLC column fabrication. This technique will give the analyst a tool to make custom 
stationary phases, which can provide a more specific coating for a given analyte or 
matrix.  The fibers assembled in this work will be used to estimate the water/octanol 
partition coefficient of β-blockers in a buffered solution. 
The second objective relates to the analysis of pharmaceutical compounds in 
complex matrices. It is a particularly challenging task even with all the sample 
preparation technologies currently available to the analytical chemist. A lot of time and 
effort is often required to obtain meaningful results from such analysis and therefore the 
area has seen a lot of efforts developed to help simplify methods. It is the goal of this 
work to demonstrate a way to prepare multiple fibres for high-throughput analysis of 
loratadine in biological samples. 
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2 Development of Silicate Triacontyl Coatings for Drug Analysis 
2.1 Preamble 
The following chapter is a modified version of a paper submitted for publication. 
The contribution of the co-author Maria Rowena M. Monton are both experimental help 
and manuscript revisions.  
I, Maria Rowena M. Monton, authorize François Breton to use the material for his 
thesis. 




 Coating procedures for the fibers have been investigated and many approaches 
have been developed to suit a wide range of analyte properties.32-37 The multitude of 
coatings for SPME fibers is crucial since it will directly determine factors such as 
selectivity, reproducibility, speed and ruggedness of a method. The majority of 
commercially available SPME fibers consists of polymeric phases (e.g., PDMS, PA, 
CW, Carboxen (CAR), or composites) coated onto fused silica. However, recent interest 
in high-porosity fibers has picked up considerably because of their large surface areas 
and consequently, high extraction capacities resulting in significant sensitivity 
improvements.  Unfortunately, fabrication protocols for highly porous coatings are often 
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based on adhesives, which have proprietary chemistries and render the process of 
coating a matter of trial and error. The adhesive must provide a rugged coating capable 
of resisting common solvents used in analyses.38 At the same time, it should not impede 
mass transfer between the sample solution and the extraction phase during the 
extraction step, and between the extraction phase and the desorption solution during 
the desorption step.  The method of attachment for the silica support is a parameter 
which cannot be overlooked. 
 The current chapter describes a new procedure for preparing silica-based 
coatings for SPME based on the entrapment of porous silica particles in a network of 
polymerized silicate, followed by in situ derivatization to attach the desired extraction 
phases.  Such an entrapment strategy has been used previously to prepare monolithic, 
particle-loaded columns for use in capillary electrochromatography (CEC),39, 40 and to 
coat the inner wall of separation capillary in capillary electrophoresis for electroosmotic 
flow control.41 Soluble silicates dry to form tough, tightly adhering inorganic bonds or 
coatings16, thereby rendering mechanically robust columns and highly stable coatings.  
We used this material to fabricate our SPME fibers, which provided us with a fiber 
capable of withstanding many extraction-desorption cycles without significant change in 
performance.  As opposed to the column configuration in CEC, the open bed format of 
SPME fibers precludes direct inclusion of alkyl-modified phases in aqueous silicate; 
thus bare silica particles were used instead, and these were subsequently derivatized 
directly onto the fiber. As opposed to conventional coatings where the particles are 
separated by networks of adhesive that do not contribute to or hinder extraction, the 
porous silica particles and the inter-particle silica entrapment matrix provide a 
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continuous surface, which can be derivatized with the required chemical moieties for 
maximum coverage and ultimately higher extraction capacities. 
 Alkyl triacontyl (C30) phases are the longest chain of monomeric reversed 
phase-LC phases currently available42. They are considered as novel, although they 
have been used previously in the separation of cis-trans carotenoid isomers, due to 
their exceptional shape selectivity43, and of fullerenes, in which the strong retention of 
the molecules was attributed to their effective interaction with the very long chains of the 
stationary phase44.  More recently, in SPE, C30 was used as sorbent for extracting 
polyaromatic hydrocarbons in airborne particulate matter45, and estrogens and their 
metabolites from water samples46.  In both cases, C30 provided superior performance 
over C18. 
  The triacontyl fibers were selected to determine their viability as a tool to 
estimate the LogP value of structurally diverse β-blockers. Traditionally LogP values are 
determined using large quantities of drug and solvents (octanol/water) in order to 
experimentally determine the hydrophobic descriptor. Increasingly, the determination is 
performed using HPLC on a C18 reversed phase column and the retention time of the 
analyte is used to determine hydrophobicity.47 However, it is still a solvent consuming 
technique requiring long columns and can be time consuming. This work exploits the 
high extraction efficiency of the developed extraction phases and the intrinsic 
advantages of the SPME technique, such as minimal solvent use, to demonstrate the 
usefulness of the fibers in determining the hydrophobic parameter of β-blocker drugs. 
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For this research, reversed phases (C4, C8, C18 and C30) for extraction were 
attached onto fibers following organosilane chemistry, thereby allowing optimization of 
extraction selectivity. The resulting SPME fibers were characterized by scanning 
electron microscopy (SEM) and evaluated for their ruggedness of preparation, 





2.3.1 Chemicals and Materials 
 
Drugs of the benzodiazepine class (see Figure 8) were selected to evaluate 
extraction qualities of the fibers prepared. Diazepam, oxazepam, nordiazepam and 
lorazepam were purchased from Cerilliant (Round Rock, TX, USA) as 1 mg/mL certified 
standards.  
    
Figure 8 Structure of benzodiazepines (diazepam, oxazepam, nordiazepam, 
lorazepam), commonly used for their sedative and anti-anxiety properties. 
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Derivatization reagents consisted of n-butyldimethylchlorosilane for assembly of 
the n-butyl (C4) hydrophobic stationary phase, n-octyldimethylchlorosilane for n-octyl 
(C8) hydrophobic stationary phase, n-octadecyldimethylchlorosilane for n-octadecyl 
(C18) hydrophobic stationary phase and triacontyldimethylchlorosilane for the triacontyl 
(C30) hydrophobic stationary phase. These organosilane reagents were purchased 
from Gelest Inc. (Morrisville, PA, USA). Great care was taken to avoid exposure to 
humidity to preserve reagent quality. 
 Potassium silicate (Kasil 1) was donated by PQ Corporation (Valley Forge, PA, 
USA). Ascentis porous silica particles (underivatized), 5 µm in diameter, were provided 
by Supelco (Bellafonte, PA, USA).  Anhydrous toluene and the β-blockers (see Figure 
9) were purchased from Sigma Aldrich (Oakville, ON, Canada). 
 
Figure 9 Structure of β-blockers used in LogP correlation experiment: 1. Alprenolol, 2. 
Atenolol, 3. Nadolol, 4. Oxprenolol, 5. Pindolol, 6. Propranolol, 7. Timolol, 8. Carvedilol. 
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 The toluene was transferred from the original container through a septum, using 
a glass syringe, in order to avoid water contamination. Tetrahydrofuran, toluene, 
methanol and acetonitrile, HPLC grade, were purchased from Caledon (Georgetown, 
ON, Canada). Hydrochloric acid and nitric acid, ACS grade, were purchased from 
Fisher Scientific (Ottawa, ON, Canada). Water was purified and deionized using a 
Barnstead Nanopure water system (Dubuque, IA, USA). Stainless steel wires, grade 
304, and a Xuron® music wire shear cutter were purchased from Smallparts (Miami 
Lakes, FL, USA). 
 
2.3.2 Coating Procedure 
 
The grade 304 stainless steel wires (0.061”) were initially chemically etched for 
30 minutes with hydrochloric acid to increase roughness of the surface and to activate 
the autoprotective hydroxyl layer of stainless steel. After a generous rinse with 
deionized water, the wires were dried in an oven at 130°C for 1 h. The dried and cooled 
wires were dipped in potassium silicate solution such that a length of 1.5 cm was 
covered, and then carefully rolled into 5-µm porous silica particles. The resulting 
silicate-silica coating was exposed to fumes of concentrated nitric acid for 10 s, which 
would set the coating together rapidly, and then was allowed to dry at ambient 
temperature for at least 12 h. To ensure thorough drying for maximum stability of the 
coating, as well as effective chemical bonding of the alkyl phases, heating in a 
programmed oven was performed. The coated fibers were initially exposed to 50°C, 
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then the  temperature was gradually increased to 95°C at the rate of 1°C·min-1 and held 
for 15 minutes. The fibers were then brought from 95°C to 150°C at the rate of 1°C·min-1 
and left to stand overnight.  This slow optimized cure was necessary since a quicker 
cure resulted in blistering and bubbling of the coating. 
The derivatization solutions consisted of 10% organosilane in anhydrous toluene 
(it was necessary for C30 to have some heating for complete dissolution). All steps 
were carried out using meticulously dry glassware and utensils.  The coated wires were 
placed in vials containing 10 mL of the organosilane-toluene solution and purged with 
nitrogen before capping. Then, the vials were immersed in a silicone oil bath maintained 
at 70°C using a hot plate for the optimal time of 24 hours.  
Following derivatization, the fibers were rinsed successively for 15-min periods 
with toluene, tetrahydrofuran, methanol, 50:50 (v:v) methanol:water and water.  Finally, 
the fibers were allowed to dry overnight before initial use.  
 
2.3.3 SPME Conditions 
 
For the preliminary characterization work, extraction of the benzodiazepines was 
performed in 2-mL HPLC vials using 1.5 mL of phosphate buffered saline (PBS, pH 7.4) 
extraction solution. Prior to first extraction, fibers were conditioned for 30 min in 50:50 
methanol:water and subjected to 5-min conditioning step between extraction-desorption 
cycles using the same conditioning solvent. Desorption was performed in 200 µL of 
50:49:1 water:acetonitrile:acetic acid contained in 200-µL bottom spring inserts. Unless 
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otherwise noted, extraction and desorption times were 15 min and 5 min, respectively. 
In both steps, the samples were agitated at 2400 rpm using a vortex shaker DVX-2500 
(VWR, West Chester, PA, USA).  
For the LogP determination work, extraction of 16 ng/mL β-blockers was performed in 
40 mL vials using 35 mL of sodium bicarbonate buffer (pH 10.5) as extraction solution. 
Extraction was performed for 1 hour. Stirring was performed using a magnetic stir bar at 
500 rpm. Desorption and conditioning were performed as described above. 
 
2.3.4 SEM and EDX Characterization 
 
The fiber coatings were subjected to preliminary evaluation using an optical 
microscope (Reichert-Jung series 40, Heidelberg, Germany).  High-magnification 
characterization of the fiber coatings was performed using a scanning electron 
microscope (SEM) LEO 1530 field emission SEM (Carl Zeiss NTS GmbH, Oberkochen, 
Germany). Prior to analysis, the fibers were dried thoroughly, and then mounted using 
carbon conductive tape and specimen mounts (Ted Pella, Redding, CA, USA). Samples 
were sputtered with ~10 nm of gold and were analyzed using an acceleration voltage of 
15 kV.  
Energy Dispersive X-ray (EDX) analysis was used to perform a semi-quantitative 
evaluation of the derivatization efficiency onto the surface of the fibers. Using the same 
SEM apparatus, increases in elemental carbon onto the silica backbone of the coating 
were determined. 
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2.3.5 LC-MS Instrumentation 
 
 An Agilent 1100 LC-mass selective detection system (Hewlett-Packard, Palo 
Alto, CA, USA) consisting of a degasser, a binary pump, an autosampler, a variable 
wavelength UV detector set at 230 nm, and a single quadrupole mass analyzer was 
used to perform characterization analysis. The model analytes were separated on an 
Ascentis C18 column (5 µm, 2.1 x 50 mm) (Supelco Inc. Bellafonte, PA, USA), 
preceded by a precolumn. Elution was carried out in isocratic mode using 50% 
10:90:0.1 acetonitrile:water:acetic acid (solvent A) and 50% 90:10:0.1 
acetonitrile:water:acetic acid (solvent B) at a  flow rate of 0.5 mL·min-1, and a total 
runtime of 6 min. The injection volume was 20 µL.  A 2-mm offset was used to prevent 
autosampler needle contact with the bottom of vial inserts.  
 LC was coupled to the mass spectrometer (MS) using an electrospray ionization 
(ESI) interface, operated in positive ionization mode. The MS parameters were: drying 
gas (N2), 10 mL∙min
-1; drying gas temperature, 300C; nebulizer pressure, 15 psi; 
capillary voltage, 4000 V; fragmentor voltage, 90 V; and quadrupole temperature, 
100°C. The analytes were detected by selected ion monitoring (SIM) mode 
(nordiazepam, m/z = 271; diazepam, m/z = 285; oxazepam, m/z = 287; lorazepam 
(internal standard), m/z = 321) using isolation peak widths of 1 amu.  
The LogP experiments were carried out on an Agilent 1200 LC system coupled 
to a Sciex API 3200 Q-trap mass spectrometer (Applied biosystems/MDS Sciex, 
Toronto, ON, Canada),  using Multiple Reaction Monitoring (MRM) scanning (see Table 
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1). The runtime was 6 minutes and the injection volume was 10 µL with a 2-mm offset. 
The β-blockers were separated on a Zorbax XDB-C18 column (5 µm, 4.6 x 150 mm) 
(Agilent, Palo Alto, CA, USA). The elution was carried out using 99.9:0.1 water:acetic 
acid (solvent A) and 99.9:0.1 methanol:acetic acid (solvent B). The elution profile 
consisted of a gradual increase from 70% B to 90% B from 0 to 4 minutes, followed by a 
30-second hold, a gradual decrease from 90% B to 70% from 4.5 to 5 minutes followed 
by a re-equilibration at 70% B for 1 minute. The flow rate was kept constant at 1 
mL.min-1 throughout the run. The mass spectrometry experiments were carried out 
using electrospray ionization (ESI) in positive mode. The curtain gas was maintained at 
45 psi, nebulizer gas at 75 psi, turbo gas at 70 psi and collision gas at 7 psi. The ion 
spray voltage was set to 3500 V and the turbo gas temperature at 750°C. Data analysis 






























Atenolol 267/145 46.00 4.50 17.63 30.00 3.00 
Nadolol 310/254 61.00 6.00 17.15 21.00 4.00 
Pindolol 249/116 56.00 10.00 21.55 37.00 4.00 
Timolol 317/261 46.00 7.00 18.83 21.00 4.00 
Oxprenolol 266/72 46.00 7.00 17.60 31.00 8.00 
Alprenolol 250/91 46.00 6.00 17.15 23.00 4.00 
Propranolol 260/116 46.00 6.00 17.43 23.00 4.00 
Carvedilol 407/100 41.00 6.00 19.03 21.00 4.00 
 
Table 1 MRM transitions and experimentally determined MS parameters for β-blocker 
compounds. 
 
2.4 Results and Discussion 
 
2.4.1 Development and Optimization of SPME Coating Procedure 
 
 In a study by Liu et al.,9 a porous layer was shown to have 500 times greater 
surface area compared to a polymer coating in SPME, resulting in as much as 8 times 
increase in the amount of analyte adsorbed.  In the present work, porous, 5-µm silica 
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beads were immobilized onto metal wires by entrapping them in networks of 
polymerized silicate.  Aqueous potassium silicate was bonded by a combination of acid-
curing and dehydration steps to render the bond insoluble, to reduce setting time, and to 
increase bonding strength16. Potassium silicate is commonly used in metal binding 
applications; hence, it can be expected to adhere strongly to the supporting wire.  When 
applied, its tackiness held the silica beads in place.   On exposure to acid fumes, the 
silicate ions polymerized readily, and the silanol groups on the surface reacted with the 
hydroxyl ions in the beads. In this manner, cross-linking siloxane clusters were formed, 
and led to a strong, coherent coating.  To strengthen it further, it was subjected to a 
dehydration step, in which the oven temperature was ramped gradually to remove 
excess water slowly and to prevent blister and bubble formation. Exposure of the initial, 
unpolymerized coating to some acids at various concentrations were evaluated to 
determine how to obtain the most consistent coating. The acids investigated were 
trifluoroacetic acid, acetic acid, nitric acid, sulfuric acid and hydrochloric acid ranging in 
concentrations from 0.1% acid in deionized water to concentrated acid. Best results 
obtained from fumes of concentrated nitric acid occurred serendipitously and provided 
desired bonding of the coating while providing us with a rapid setting. Under SEM, the 
resulting silicate layer was found to be uniform with a thickness of ~ 3 µm.  By rolling the 
wire dipped in silicate over the silica particles with a gentle, constant speed, a dense yet 
even loading of particles onto the surface could be achieved.  As shown in the electron 
micrograph in Figure 10, the particles were only partially submerged in the entrapment 
matrix, forming a monolayer. This formation could maximize the surface area while 
keeping the thickness at a minimum.   
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Figure 10 Scanning electron micrograph of an SPME fiber prepared by entrapping 5-
µm porous silica particles in polymerized silicate.  Derivatization with C18 performed in 
situ. 
 
Preliminary evaluation of the ruggedness and robustness of the resulting 
coatings were done by a scratch test using a lint-free tissue paper, and 1-min sonication 
using 50:50 methanol:water.  Fibers were considered suitable for subsequent 
organosilane reaction if no obvious changes in coating integrity could be observed 
under an optical microscope.   
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In contrast to the column configuration in CEC, the open bed format of SPME 
fibers does not allow direct inclusion of alkyl-modified phases in aqueous silicate; thus 
bare silica particles were used instead, and these were subsequently derivatized on-
fiber. As opposed to conventional coatings where the particles are separated by 
networks of adhesive that do not contribute to, and may hinder extraction; the porous 
silica particles and the inter-particle silica entrapment matrix provide a continuous 
surface, which has the potential to be completely derivatized with the chosen chemical 
moieties. This approach could provide maximum coverage and therefore allow higher 
extraction capacities. 
 Alkyl derivatizations (using n-butyldimethylchlorosilane for C4, n-
octyldimethylchlorosilane for C8, n-octadecyldimethylchlorosilane for C18, 
triacontyldimethylchlorosilane for C30) were performed according to the procedure 
described by Fields,48 modified to fit the on-fiber format.  Following derivatization, 
elemental analysis was performed using EDX to determine the increase in carbon 
content.  An underivatized coated fiber and another that was derivatized with C18 phase 
were analyzed and compared.  Results showed a 15% by weight increase in carbon 
content at the surface of the latter, indicating successful attachment of the alkyl phase. 
To assess reproducibility, five independent batches of C18 fibers were prepared 
and the amount of benzodiazepines extracted and desorbed were determined by LC-
MS following normalization using lorazepam as internal standard to correct for 
differences in injection volumes. The concentration of diazepam was maintained at 12.5 
ng/mL while the others were maintained at 25 ng/mL. Results (Table 2) show that the 
fiber-to-fiber relative percent standard deviation (intra-batch) %RSD was within 18.6, 
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whereas the batch-to-batch (inter-batch) %RSD was within 20.2. These values attest to 
the ruggedness of the coating preparation protocol.  
Batch number 
Percent Extracted (n=6) 
Nordiazepam Diazepam Oxazepam 
Mean % RSD Mean % RSD Mean % RSD 
1 5.9 8.0 16.3 11.7 4.0 17.1 
2 7.1 12.8 19.8 17.6 5.0 18.1 
3 5.9 15.5 19.3 11.9 4.8 18.3 
4 7.9 10.5 23.3 14.4 5.2 16.1 
5 6.6 14.1 20.3 18.6 4.2 14.1 
Interbatch (n=30) 6.7 15.7 19.8 20.2 4.6 19.8 
 
Table 2 Fiber-to-fiber and batch-to-batch reproducibility using C18 fibers. 
 
To determine endurance and reusability, a C18-coated fiber was subjected to a 
series of 100 successive conditioning (5 min)-extraction (2 min)-desorption (5 min) 
cycles, and the ratio of the amount of oxazepam was calculated for each cycle. The 
average response in injections 50-52 and 98-100 were found to be 96.6% and 88.9%, 
respectively, of the average response in injections 1-3 (Figure 11). 
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Figure 11 Ruggedness of the coated fibers as represented by extraction efficiencies. 
 
  The sturdiness of the coated fiber can be attributed to the interplay of four 
factors, namely good mechanical strength of stainless steel as supporting material, 
strong adhesion of silicate onto metal, effective immobilization of the silica beads in 
silicate, and robustness of the chemically bonded alkyl phase. Additionally, some fibers 
were kept continuously in 50:50 methanol:water for a period of one month, and no 






2.4.2 Extraction and Desorption Properties 
 
Fibers that were coated with porous silica particles entrapped in silicate, which 
were not derivatized, as well as fibers coated with silicate alone, but which were 
derivatized with C18 phase, did not extract any detectable amount of the test analytes.  
While the latter group contained silanol sites that could be alkylated, and therefore be 
subsequently used for extraction, the amount of analytes extracted were likely too low to 
be detected by the method.  In contrast, fibers prepared by fixing porous silica particles 
with silicate, which have been subjected to derivatization, successfully extracted 
benzodiazepines.   
In a study on the effect of the alkyl group (C1, C6, C8 and C18) bonded to the 
silica phase on the selectivity of extraction of polycylic aromatic hydrocarbons (PAHs) 
using SPME49, it was demonstrated that small-chain alkyl-containing phases were better 
able to extract larger PAHs.  This behaviour was attributed to the restriction imposed by 
longer chains on bulkier molecules, limiting their access to the full extent of the 
hydrophobic surface.  On the other hand, in the present study, a comparison of the 
amount of benzodiazepines extracted using C4-, C8-, C18- and C30-coated fibers 
showed that the amount extracted increased with increasing alkyl chain length (Figure 
12).  The model analytes used here are small molecules belonging to the same 
compound class, and are therefore largely coherent structurally.  Differences in 
extraction yield may be thought of as a function of hydrophobicity, with the more 
hydrophobic compound being extracted better, and in more hydrophobic extraction 
phase (i.e., greater hydrophobic space for enhanced interaction with the analyte). 
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Figure 12 Comparison of extraction efficiencies (% extracted) for C4, C8, C18 and C30- 
derivatized fibers using selected benzodiazepines.  Conditions are as described in 
Experimental Section of this chapter. 
 
Generally, SPME fibers prepared by gluing discrete particles together make use 
of the same sorbents utilized in solid phase extraction (SPE), or the same stationary 
phase particles used for packing LC columns, with C18 being the most common for 
reversed-phase (RP) systems. On the assumption that small, hydrophobic molecules 
could be better extracted the more hydrophobic the extraction phase is, we prepared 
C30-coated SPME fibers.  As shown in Figure 4, C30 was able to extract 
benzodiazepines much better, even compared with the most commonly employed 
extraction phase in this series, i.e., C18.  According to the solvophobic theory in LC, 
retention of analytes on the stationary phase is dependent on the molecular contact 
area between the solute and the stationary phase.50 For a given solute, retention is 
expected to increase with the alkyl chain length of the bonded phase.  
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Extraction profiles using C18 (Figure 13A) and C30 (Figure 13B) fibers were 
prepared. For C18, equilibrium times as fast as 2 min could be obtained under the 
current conditions. Fast equilibration was rendered possible by the ultrathin layer (about 
20 Å) of the extracting phase; thus, the influence of diffusion kinetics could be 
considered negligible 9. The design of the fiber itself also allows for maximum rate of 
mass transfer to be achieved since the coating approach creates derivatized porous 
surfaces which are unhindered and situated at the surface of the coating, whereas 
approaches where particles are applied as slurry creates thicker coatings and the cured 
product might also block easy access to the derivatized surface. Due to this 
improvement in rapidity, it becomes advantageous to investigate C30 since the increase 




Figure 13 Extraction time profiles for benzodiazepines using C18 fibers (A) and C30 (B) 






Calibration lines were determined using C18 and C30 fibers (Table 3). In both 
cases, all three compounds showed a linear response over a concentration range of two 
orders of magnitude.  The slopes of the calibration lines using C30 fibers were steeper 
than the corresponding lines using C18 fibers, further attesting to increased sensitivity 













Nordiazepam 2 - 200 1015 0.9873 4987 0.9934 
Diazepam 2 - 200 2622 0.9938 9733 0.9971 
Oxazepam 2 - 200 309 0.9993 1659 0.9975 
 
Table 3 Calibration range and linearity of response using C18 and C30 fibers. 
 
2.5 LogP Determination using C30 Fibers 
 
 The interest with C30 stems from the increase in sensitivity shown towards more 
hydrophilic drugs. This particular quality would allow the fibers to have a wider dynamic 
range on the LogP scale to properly assess the hydrophobicity factor of the β-blockers. 
To determine if the SPME fibers developed could be used for LogP determination of 
pharmaceutical compounds we have assembled a list of 8 β-blockers and determined 
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their equilibrium profile. The volume of the sampling solution was increased to 35 mL in 
order to prevent depletion of the analyte in solution and provide a representative K 
value for the fibers. Carry-over of the fiber was determined to be at most 2.0% for the 













Table 4 Carry-over of the β-blockers using C30 extraction phase. 
 




      [6] 
Results for the experimentally determined Kfs values can be found in Table 5 along with 






Kfsexperimental LogPliterature pKaliterature 
Atenolol 266.4 
(2.8 ± 0.2) x 
101 
0.1c, 0.22e, 0.23h, 
0.026i, 0.16b, 0.25g 
9.6c, 9.54e, 9.3h, 9.17i, 
9.6b, 8.07g 
Nadolol 309.4 
(1.5 ± 0.1) x 
102 
0.71h, 1.17i, 1.0g 9.7h, 9.17i, 9.4b, 9.0g 
Pindolol 248.3 
(1.0 ± 0.1) x 
102 
1.83e, 1.48i, 1.75b, 
1.91g 
9.54e, 9.21i, 9.7b, 6.98g 
Timolol 316.4 
(3.8 ± 0.2) x 
102 
2.12e, 1.91f, 1.75i, 
1.91b, 1.98g 
9.53e, 9.21f, 8.86i, 
9.21b, 9.19g 
Oxprenolol 265.3 
(6.6 ± 0.5) x 
102 
2.94d, 2.51e, 2.18h, 
1.83i, 2.18b, 2.3g 
9.57e, 9.6h, 9.13i, 9.5b, 
9.08g 
Alprenolol 249.3 
(1.1 ± 0.1) x 
103 
3.1e, 3.1f, 2.61h, 
2.81i, 3.1b, 3.15g 
9.59e, 9.65f, 9.6h, 9.19i, 
9.65b, 9.34g 
Propranolol 259.3 
(1.6 ± 0.2) x 
103 
3.1c, 3.48e, 3.56f, 
3.65h, 2.6i, 3.56b, 
3.41g 
9.53e, 9.45f, 9.5h, 9.15i, 
9.5b, 9.25g 
Carvedilol 406.5 
(1.6 ± 0.1) x 
104 
4.1a, 4.23d, 4.11e 7.8a, 7.9d, 7.97e 
 
References: a 52, b53, c54, d55, e56, f57, g58, h59, i60 
Table 5 Experimental and literature values used for LogP determination of β-blockers 
by SPME. 
 
A correlation was established to determine if the triacontyl fiber could be used to 
determine the hydrophobicity factor of the pharmaceuticals of interest. As can be seen 
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in Figure 14, a regression analysis showed clear correlation with a R2 = 0.9255 between 
the values found in literature and the Kfs values obtained using the triacontyl fibers at 
equilibrium (teq = 1 hour). Given the variability between different methods to determine 
LogP, the method at hand is able to provide a rapid determination of this physical 
parameter without the need for large amounts of drug or solvents. 
 
Figure 14 Comparison of the β-blocker LogKfs values obtained experimentally using 
SPME, with the LogP values obtained from literature results. 
 
The design of the fiber itself also allows for maximum rate of mass transfer to be 
achieved since the coating approach creates derivatized porous surfaces which are 
unhindered and situated at the surface of the coating, whereas approaches where 























particles are applied as slurry creates thicker coatings and the cured product might also 
block access to the derivatized surface. Due to this improvement in rate of mass 
transfer, it becomes advantageous to investigate C30 since the increase in equilibrium 


















 The method described in this chapter provides a unique approach to the 
development of SPME fibers using well known technologies such as monolith casting 
and organosilane derivatization.  Covalent immobilization of the various alkyl phases 
resulted in a robust and reproducible extraction coating that could be easily optimized 
for sample extraction selectivity and equilibrium time.  This approach should permit the 
development of a wide range of coatings with tailored extraction properties to meet the 
needs of fast and efficient sample preparation in analytical chemistry. Covalent 
immobilization of the various alkyl phases resulted in a robust and reproducible 
extraction coating that could be easily optimized for sample extraction selectivity and 
equilibrium time.  In the present study, it was demonstrated that C30 could be used to 
increase the sensitivity of benzodiazepine analysis over shorter alkyl chain extraction 
phases. It was also demonstrated that C30 can be used to estimate the LogP value of 
drugs and therefore provide a simple, rapid and reproducible way to estimate the 
octanol-water partition coefficient in early stages of pharmaceutical development. The 
present SPME fiber preparation, in combination with the well established organosilane 
surface derivatization, should help create a variety of surface chemistries and increase 





3 High-throughput Automation for Drug Analysis 
 
3.1  Introduction 
 
The various advantages of SPME, namely its simplicity, size and speed, make it 
an ideal technology for high-throughput sample analysis. The importance of SPME 
automation for routine analysis has been recognized early in environmental sample 
analysis.23, 25 SPME is also a well established technique for drug analysis, as recently 
outlined in several reviews.30, 61-67 Automation of SPME for bioanalysis has mainly 
focused on the area of in-tube SPME,22, 68 however, this approach requires processing 
of samples in a serial fashion.  Most recently, there have been efforts to demonstrate 
the suitability of SPME for 96 well-plate sample analysis of drugs in biofluids using 
commercially available fibers.69 Although this work requires manual processing, this 
parallel and high-throughput analysis approach is necessary to meet the demands of 
drug analysis in biological samples.   
Thus, the advancement of SPME as a technology used in large scale bioanalysis 
requires the development of robust, high-throughput and automated fiber fabrication 
protocols in order to obtain and process a large number of sampling devices, while 
maintaining rugged and uniform coatings for reproducibility.  Furthermore, the amount of 
commercially available coatings on the market for high-throughput sampling in biological 
samples is limited and can necessitate fabrication in situ.  This process is lengthy and 
requires a fair amount of optimization in order to obtain an acceptable sampling device. 
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We propose a high-throughput assembly procedure for a C18 SPME fiber using robotic 
assistance to help us achieve a uniform and rugged coating. The same robotic 
apparatus is then used for high-throughput sample preparation of loratadine in human 
plasma. Traditionally, fibers that are not commercially available to analyze a given 
compound are manually constructed by immersing a support material such as silica or 
stainless steel into the desired coating material. Silica bonded phases have shown 
desirable properties as coatings due to their large specific surface area. 9 Various 
coating procedures can be used to provide the desired parameters of the coating; 
however, the conditions under which the fiber preparation is performed can be tedious 
and hard to control (relies heavily on manual skills). To assemble the fibers using a 
simple and rugged method was one of the aims of our research to improve high-
throughput. Our method therefore helped reduce manual labour induced errors in the 
fiber preparation step and provided many fibers at once, which in turn provided a fast 
and efficient way to perform high-throughput drug analysis. 
The evaluation of our fiber preparation and extraction procedure was performed 
using loratadine, a long-acting tricyclic antihistamine with selective peripheral histamine 
H1-receptor antagonistic activity, as a model analyte (Figure 15). Loratadine is a widely 
used allergy medication which has been analyzed in biological fluids by HPLC with 
mass spectrometry.70-77 The majority of the methods used to determine loratadine in 
biological fluids relies on time consuming liquid-liquid extractions that are typically 
difficult to automate.  
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Figure 15 Molecular structure of loratadine (M.W. 382.89). 
 
The objective of this work was to provide a fast, low cost, and reproducible method 
for SPME fiber preparation, capable of detecting loratadine within its therapeutic range. 
In our study, a custom designed robotic apparatus was used to automate the fibers 
preparation process in combination with the sample extraction procedure for the high-




3.2.1 Chemicals and Materials 
 
Loratadine [ethyl 4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-
11-ylidine)-1-piperidinecarboxylate], and Loratadine-d4 were supplied by Merck Frosst 
and Co. (Kirkland, QC, Canada). Discovery C18 5m silica particles were donated by 
Supelco (Bellefont, PA, USA). Ammonium acetate and acetic acid were purchased from 
Sigma-Aldrich (Oakville, ON, Canada). Acetonitrile, methanol, and isopropyl alcohol, 
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HPLC grade or better, were purchased from EMD Chemicals Inc. (Gibbstown, NJ, 
USA). Hydrochloric acid, ACS grade, was purchased from Fisher Scientific (Ottawa, 
ON, Canada), chloroform, ACS grade, was purchased from J.T. Baker (Phillipsburg, NJ, 
USA). Human Plasma EDTA was purchased from US Biologicals (Swampscott, MA, 
USA) and stored at -20°C. 353ND epoxy was purchased from Epoxy Technologies 
(Billerica, MA, USA). 96 deep well-plates (1 mL and 2 mL) were purchased from VWR 
(Mississauga, ON, Canada). Stainless steel wires grade 304 and a Xuron® music wire 
shear cutter were purchased from Smallparts (Miami Lakes, FL, USA). Samarium cobalt 
magnets (SmCo grade 18) were purchased from Master Magnetics (Castle Rock, CO, 
USA). Deionized water was obtained by a Barnstead Nanopure water system 
(Dubuque, IA, USA). 
 
3.2.2 SEM Characterization 
 
High magnification characterization of the fiber coatings were performed using a 
scanning electron microscope (SEM) LEO 1530 field emission SEM (Carl Zeiss NTS 
GmbH, Oberkochen, Germany). Prior to analysis, the fibers were dried in an oven at 
150°C for at least 2 hours in order to remove any moisture. Carbon conductive tape and 
specimen mounts (Ted Pella, Redding, CA, USA) were used to immobilize the samples 
for analysis. Sections of the fibers were cut into 7 mm lengths for horizontal views, or ~1 
mm for a cross-sectional view. Prior to analysis, samples were sputtered with ~10 nm of 
gold and were analyzed using an acceleration voltage of 15 kV. Preliminary 
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characterizations were performed using an optical microscope (Reichert-Jung series 40, 
Heidelberg, Germany). 
 
3.2.3 LC-MS/MS Instrumentation 
  
A Varian (Palo Alto, CA, USA) 500-MS Ion Trap coupled to a 430 autosampler 
for 96 well plates and 212-LC pumps was used for this work. The chromatography was 
achieved using a Merck (Darmstadt, Germany) Chromolith Flash RP-18e column (4.6 x 
25 mm) preceded by a Varian Pursuit C18 A3000MG2 pre-column. The mobile phase 
gradient consisted of 28% mobile phase A (90:10:0.1 (v/v) water:acetonitrile:acetic acid) 
changing to 90% mobile phase B (10:90:0.1 (v/v) water:acetonitrile:acetic acid) over 4.3 
minutes  at a flow rate of 1 mL/min, followed by re-equilibration for the column over 2.7 
minutes.  A Valco® t-splitter was used to obtain a 0.25 mL/min flow rate to the MS 
module. A needle wash solution of 50% methanol and 50% water was used with the 
autosampler. The injection volume was 20 µL.   
The mass spectrometry experiments were performed using an electrospray 
ionization (ESI) interface in positive mode. The capillary voltage was maintained at 
+94V, Rf loading was set to 93%, and excitation amplitude was 0.86. The ESI housing 
was kept at 50°C, the drying gas was set to 400°C and 30 psi. The spray shield voltage 
was set to +600V and the needle voltage to +3600V. The mobile phase was diverted 
from the source except between t = 1.5 to 3.5 minutes to prevent contamination of the 
source.  MRM mode was used for the quantitation of the analytes by LC-MS/MS. The 
precursor  product ion transitions were at m/z 383/337 for loratadine and m/z 387/341 
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for the d4-loratadine.  Data acquisition was done using a PC with the Varian MS 
Workstation software. 
 
3.2.4 Preparation of Stock Solutions and Samples 
 
A stock solution of loratadine and d4-loratadine was prepared at 1 mg/mL in 
acetonitrile. The loratadine stock was further diluted in acetonitrile to obtain working 
solutions of 5, 10, 20, 50, 100, 200, 500, 1000, 2000 and 5000 ng/mL. A working 
standard of 200 ng/mL of the d4-loratadine was prepared in acetonitrile. All working 
solutions were stored at 4°C and the stock solutions at -20°C. 
After thawing the plasma samples, 37.5 µL of the working standards and internal 
standard was added to 675 µL of human plasma. Buffer samples were prepared in a 
similar fashion using 40 mM ammonium acetate adjusted to pH 6.8 using acetic acid. 
For the purposes of characterization and evaluation of the fibers for loratadine 
extraction, the internal standard was added after the extraction step in the final 
reconstitution solution. 
 
3.2.5 Preparation of Adhesive 
 
The Epotek 353ND adhesive was received as a 2 part kit. The ratio of part A:B 
was kept constant at 10:1 (w/w). Initially, 20 g of part A resin was weighed in a 40 mL 
screw cap vial and 16 mL of chloroform was added to the resin. The mixture was 
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magnetically stirred at 700 rpm for 30 minutes. Once homogenized, 2 g of part B 
hardening agent was added to the part A mixture and mixed well for 15 minutes under 
similar conditions. A quantity of 14 mL of the adhesive was required to fill the well of our 
coating apparatus. 
 
3.2.6 Automated SPME Coating Procedure 
 
A robotic arm (PAS Technology Deutschland GmbH, Magdala, Germany) 
designed for use as a multifunction autosampler was programmed using the Concept® 
Software to automatically coat 96 fibers with stationary phase using a novel custom built 
96 fiber holder device (Figure 16). Grade 304 stainless steel wires (1.55 mm outer 
diameter) were cut into 5.5 cm fibers using an in-house modified Xuron® music wire 
shear. The resulting small wires were chemically etched in concentrated hydrochloric 
acid for 1 hour followed by a generous rinse with deionized water. The wires were dried 
at 150°C for at least 2 hours and allowed to cool to room temperature. Fibers were 
loaded onto the 96 fiber holder and retained by the individual magnets embedded in the 
holder (Figure 16). The 96 fiber holder was then properly coupled to the robotic arm and 
the software allowed the fibers to be coated row-by-row of 12 fibers into a modified 96 
deep well plate with wells of 2 mL. 
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Figure 16 Schematic of the fiber holder apparatus with embedded samarium cobalt 
magnets. 
 
 The rows were sequentially dipped into the modified epoxy adhesive followed by 
blotting with an adsorbent material and finally into a section containing the Discovery 
C18 particles. The total program running time was under 6 minutes for the entire 96 
fibres coating procedure. Once coated, fibres were removed from the robot and the 96 
fibre holder was placed upside down for cure in a GC oven at 150°C for 1 hour, and 
then allowed to cool to room temperature. A secondary cure of 150°C for 1 hour was 
performed to insure maximum bonding of the particles to the wire. An aluminum rod 
specifically designed to suspend the 96 fibre holder in a sonication bath using a retort 
stand was used to sonicate the fibres in 10% acetonitrile, 90% water to remove any 
particles which had poor adhesion to the wire before they are used.  
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3.3 Results and Discussion 
 
3.3.1 Development and Optimization of SPME Coating Procedure 
 
Experiments were performed to determine the reproducibility of the robotically 
applied coatings and to utilize the SPME fibres for the accurate determination of 
loratadine in human plasma samples.  The coating reproducibility was evaluated using 
loratadine spiked buffer samples.  All experiments were carried at room temperature 
using a final concentration of 10% acetonitrile in the extraction solution due to 
loratadine’s low solubility in water.  
An octadecyl stationary phase was selected due to the hydrophobic nature of 
loratadine (LogP of 4.4 - 5.7). 78, 79 The particular homogeneity and low density of the 
Discovery C18 5 µm particles was crucial in obtaining a uniform coating. After 
investigating various adhesives, Epotek 353ND was determined to provide excellent 
adhesion of the stationary phase to the fiber support. Physical strength and robustness 
of the coating was determined to be of good quality if scratching the stationary phase 
with finger pressure using a kimwipe did not remove the particles as observed through 
an optical microscope at 30X. Furthermore, the integrity of the coating was also 
monitored via optical microscopy and maintained after exposure to sonication in various 
solvents. In order to obtain a thin, uniform but robust coating, the adhesive viscosity had 
to be modified by diluting Part A with chloroform.  SEM was utilized to monitor the 
uniformity of the particles at the surface of the fiber and the thickness of the adhesive 
layer at various epoxy dilutions (See Figure 17).  An adhesive thickness of 6-8 µm was 
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achieved at an optimum of 80% (v/w) chloroform in part A epoxy.  This enabled a 
uniform monolayer of particle to be immobilized; improving the extraction kinetics of the 
fibers and yielding a more high-throughput application.   
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Figure 17 SEM bondline of the adhesive without stationary phase (A). Final product of 




The choice of dilution using chloroform was determined to be the best approach 
since the coating procedure had to be easily amenable to automation. Alternatively, a 
96 well plate warmer could also have been employed to slightly increase the 
temperature of the adhesive and decrease the viscosity of the adhesive. Manual 
approaches, such as brushing the adhesive on the wires, was considered too time 
consuming and irreproducible.  
 
3.3.2 Optimization of the Automated Coating Procedure 
 
In order to reproducibly coat each fibre on the fiber holder it was important to 
control tightly the adhesive application. The 96 fiber holder previously developed by 
Cudjoe et al.80 was modified in order to provide us with a coating platform that would 
have a strong hold on individual fibers while being easy to use and, most importantly, 
capable of withstanding the high cure temperatures. The holder, as shown in Figure 16, 
consists of a plate (plate 1) containing 96 holes, to provide for lateral stability of the 
fibers during agitation. Evenly distributed spacers are then sandwiched between 
another, thicker plate (plate 2), with holes aligned with the previous plate to insert the 
upper part of the fiber, for rigidity. In this second plate we have larger holes above the 
holes where the fiber is inserted. These larger holes are about 6.4 mm in diameter and 
6.4 mm deep and are filled with cylindrically shaped samarium cobalt magnets of similar 
dimensions. These rare earth magnets were selected for their strong magnetic energy 
and resistance to high temperatures. A last plate (plate 3) is finally applied over the 
magnets and screwed into place. This last plate’s purpose consists of holding the 
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magnets into their seat and also has the proper coupling piece to be installed on the 
robot assembly. The design permitted a hands-off approach therefore eliminating 
possible manipulation errors of the uncured coatings resulting in discrepancies in fiber 
capacities. It also prevented the tedious need to remove every fiber from the holder to 
cure. This approach could also potentially allow fibers to be cured as part of the 
automation process if for example fibers were lowered into a heater at the proper cure 
temperature. 
In order for every fiber to be coated to the same length, the support wires had to 
be of identical length. This was achieved by modifying a Xuron music wire shear, which 
provided a straight cut in itself, and to install a guide that would permit equal segment 
lengths of 5.5 cm.  
The container holding the coating material consisted of a 2 mL deep well plate, 
modified to the specifications depicted in Figure 18. The wide sides of the plate had to 
be removed to prevent the fibers from touching the plate sides when lowered. The 
second modification consisted of creating a trench in row 1 where the adhesive is 
located. This step was performed to prevent small changes in the adhesive volume from 
influencing the coating length.  
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Figure 18 Modified 2 mL deep well plate used for automated coating procedure. 
 
The total volume of adhesive used in this well was 14 mL, which was 18 mm 
from the top of the well. The low volume of adhesive required for the coatings allowed 
for a minimal change in volume of the adhesive well, however the well was adjusted to 
the fill line after each coating procedures. By having a single unseparated row the 
adhesive fill line would not be subjected to well-to-well irreproducibilities. The second 
row was loaded with individual cubic pieces of foam with sides of 70 mm which was 
coated with a light adhesive on one surface and a piece of kimwipe of similar 
dimensions was fixed on the upper surface by the light adhesive, deposited in each well 
using tweezers. This step was required to remove any droplet of adhesive which would 
accumulate at the bottom of the wire during the adhesive coating procedure. The third 
row was loaded with the particles up to within 3 mm from the top of the plate. The 
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parameters of the components in the 3 rows were adjusted to complement the 
Concept® software dipping procedure.  
The dipping procedure, controlled from the Concept® software, was optimized to 
minimize any displacement of the adhesive and prevent uneven coatings. Initial work 
was carried by a simple dip at every step. This procedure yielded fibers with an even 
coating of adhesive, however poor coating of particles as observed by optical 
microscopy. It was observed that the quality of the coating was better with an agitation 
at ~250 rpm where C18 particles were thoroughly covering the adhesive. An 8 mm 
offset from the adhesive was required to prevent an uneven finish of the fiber coatings. 
Care was taken to ensure that the fiber holder was lowered without any inclination by 
using a digital level.  
 
3.3.3 Optimization of the SPME conditions 
 
Optimization of the SPME conditions was performed using hand fabricated fibers. 
The minimum time required to reach equilibrium and optimal sensitivity was determined 
to be 30 minutes using an agitation of 850 rpm. The experiment was performed using 
750 µL of a 100 ng/mL loratadine solution consisting of 10% acetonitrile and 90% buffer. 
The desorption step was then optimized by monitoring the amount of analyte desorbed 
from the fibers and the residual carry-over. For high-throughput applications a removal 
of the analyte in a minimum time is required. We investigated the use of 3 desorption 
solvents to determine which of these would extract the analyte completely and rapidly. 
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Methanol and acetonitrile were found to achieve complete desorption faster than 
isopropyl alcohol (Figure 19). 
 
Figure 19 Desorption time profiles of loratadine using various solvents. 
 
 Acetonitrile was chosen and the use of 5 minute desorption was used since no 
more than 0.4% carry-over was detectable in a successive desorption after 5 minutes, 
as compared to isopropyl alcohol, which had consistently above 1.5% carry-over even 
after 5 minutes. Also, the short desorption times are desirable to avoid problems with 
evaporation of the desorption solvent. In our case, fiber carry-over was reduced to 





3.3.4 Validation of the Automated Coating Procedure 
 
The 96 fiber coating procedure was validated by repeating the coating procedure 
and monitoring if a change in extraction capacity was observed. Initially, our focus was 
to determine if coating the fibers a certain time away from the initial mixing of both parts 
of the epoxy would modify the amount we extract. This measure of the amount 
extracted would then tell us if polymerization or changes in the adhesive properties 
would significantly modify the qualities of our coating. Using 7 fibers situated in 
approximately equidistant positions on the plate we obtained the amount extracted from 
our fibers which is directly related to the amount of stationary phase (coating) we have 
on our fibers. It was determined that for a 4 hour period, no significant change in the 




Figure 20 Determination of the effect of time on the epoxy preparation by observing 
capacity of fibers fabricated at different times. t=0 is considered to be the mixing of both 
components of the epoxy. 
 
To determine if the coating procedure was reproducible, 5 batches of fibers (n=7) 
were prepared and evaluated for their extraction efficiency. Repeating the whole 
process produced fibers of similar capacity and sensitivities (Figure 21). 
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Figure 21 Batch-to-batch reproducibility of the fiber preparation. 
 
 The variation between fibers in each batch was also comparable as indicated by a 
9.0% RSD for the evaluated fibers (n=35).  
 
3.3.5 Application and Validation of Fibers in Human Plasma 
 
The linearity of the SPME-LC-MS/MS method was determined using both buffer 
and human plasma samples as described previously. The calibrations gave linearity of y 
= 0.126x – 0.019 (R2 = 0.999) and y = 0.129x + 0.035 (R2 = 0.999) for buffer and human 
plasma respectively. The lower limit of quantitation (LLOQ) for the method in each 
matrix was determined to be the lowest sample concentration (n=3) which would give us 
a RSD (%) equal or less than 15%. The LLOQ in buffer was determined to be 0.5 ng/mL 
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with a RSD of 6.9%, and the precision at all other concentrations was determined to be 
equal to or lower than 5.3%. In human plasma the LLOQ was determined to be 1.0 
ng/mL with a RSD of 6.0%, and the precision at all other concentrations was determined 
to be equal to or lower than 4.5%. 
The accuracy of the method was determined by using replicate analysis (n=3) of 
the drug compound in both buffer and plasma. It was found that the precision of the 
method, with different concentrations of drug, was acceptable as indicated with 

















Mean 0.20   





Mean 12.44   





Mean 32.48   




Table 6 Precision intra-assays of loratadine in spiked human plasma. 
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The stability of the stock of loratadine was investigated by preparing a fresh stock 
solution and determining the response factor of both standard solutions. The stock was 
stable for 10 days as the response was < 2.0% from the original solution (n=5) over this 
timeframe.  In order to know if our assay was reproducible, we determined that intraday 
variation (n=5) was 3.0% in buffer solution and 3.2% in human plasma. The interday 















Table 7 Interday reproducibility of the fibers in human plasma. 
 
  The specificity of the SPME LC-MS/MS method is demonstrated by a 
representative chromatogram of human plasma with and without loratadine (Figure 22). 
The sample clean-up provided by the C18 SPME coating and the selectivity of the LC-
Trial # 
Day 1 Day 2 
Ratio Std/ISTD 
1 12.58 13.89 
2 12.55 13.24 
3 12.59 12.79 
4 12.86 12.99 
5 12.17 13.04 
 Mean 12.87 
 RSD (%) 3.63 
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MS/MS fragmentations transitions, effectively eliminated any background interferences 
as indicated by the absence of any peaks in the blank plasma baseline.   









Figure 22 Specificity of the method for loratadine in plasma at LLOQ (1 ng/mL). 
 
The ruggedness of our coatings was investigated by repeated use of 6 fibers over 
20 extractions and no deterioration of the coating qualities were observed. Care was 
taken to prevent carry-over by performing a second desorption before a re-equilibration 






The highly uniform, and reproducible nature of the fibers prepared using a robotic 
apparatus, confirms the ability of SPME as a technology well adaptable to high-
throughput oriented laboratories. The developed approach, in combination with the 
number of particulate extraction material that is commercially available, will allow for the 
simple manufacture of SPME fibers with a range of coating extraction chemistries, 
extending the versatility of the approach. Full automation of the fiber preparation, and 
sample extraction and desorption process also demonstrates the feasibility of high-
throughput fiber fabrication for quantitative analysis of drugs in biological matrices. The 
developed method for the analysis of loratadine proved sensitive and reproducible for 
the determination of drug concentrations in human plasma samples.  Above all, the 













The outcome of this work is the development of a novel fiber consisting of a 
triacontyl covalently bonded phase using a highly porous silica backbone. The fiber 
proved successful at extracting high amount of benzodiazepines as compared to shorter 
chain alkyl phases. It was also successful at establishing a relationship between the 
hydrophobic LogP value of β-blocker drugs in buffer and LogKfs, thereby greatly 
reducing the amount of drug and solvent required to find this physical parameter. We 
have also shown the possibility to make 96 fibers with high uniformity which can be 
used to perform parallel analysis of multiple samples of biofluids using a robotic 
apparatus, thereby minimizing time of sample preparation as well as minimizing the 
need for analysts to come into contact with the biological material.  
Through this work we hope to have demonstrated some possibilities and 
advantages of using SPME to simplify pharmaceutical development. The new coatings 
and methodology could greatly reduce the difficulty and tediousness of some current 









 Care must be used when handling porous silica materials (derivatized or not) 
since their small size makes them easily inhalable. Concentrated acids and their fumes 
are hazardous and must be manipulated with necessary safety equipment in a 
fumehood. Human biological materials used in this work should be handled with care 
due to the possibility of harmful pathogens. Some of the adhesives used in this work are 
corrosive and toxic, proper safety equipment must be worn during handling. All 
chemicals, solvents, biofluids should be discarded according to University of Waterloo 
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